The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

CelluCare Blood Sugar Support Formula helps regulate glucose levels, improve insulin sensitivity, and reduce sugar cravings ...

Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...